Teligent Operating Margin 2010-2021 | TLGT

Current and historical operating margin for Teligent (TLGT) over the last 10 years. The current operating profit margin for Teligent as of June 30, 2021 is 0.00%.
Teligent Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2021-06-30 $0.05B $-0.14B -300.00%
2021-03-31 $0.05B $-0.13B -262.00%
2020-12-31 $0.05B $-0.14B -311.11%
2020-09-30 $0.05B $-0.04B -72.55%
2020-06-30 $0.06B $-0.03B -50.91%
2020-03-31 $0.06B $-0.02B -38.98%
2019-12-31 $0.07B $-0.01B -12.31%
2019-09-30 $0.07B $-0.01B -10.61%
2019-06-30 $0.07B $-0.01B -12.12%
2019-03-31 $0.06B $-0.01B -21.88%
2018-12-31 $0.07B $-0.02B -22.73%
2018-09-30 $0.06B $-0.02B -28.33%
2018-06-30 $0.05B $-0.02B -45.28%
2018-03-31 $0.06B $-0.02B -34.55%
2017-12-31 $0.06B $-0.01B -20.00%
2017-09-30 $0.06B $-0.01B -7.94%
2017-06-30 $0.07B $0.00B 4.41%
2017-03-31 $0.07B $0.00B 5.97%
2016-12-31 $0.06B $0.00B 3.17%
2016-09-30 $0.06B $-0.00B -1.61%
2016-06-30 $0.06B $-0.00B -1.72%
2016-03-31 $0.05B $-0.00B -8.00%
2015-12-31 $0.05B $-0.00B -8.89%
2015-09-30 $0.05B $0.00B 6.52%
2015-06-30 $0.04B $0.00B 7.32%
2015-03-31 $0.04B $0.01B 13.16%
2014-12-31 $0.03B $0.00B 11.76%
2014-09-30 $0.03B $0.00B 3.70%
2014-06-30 $0.02B $0.00B 4.17%
2014-03-31 $0.02B $0.00B 4.55%
2013-12-31 $0.02B $0.00B 5.26%
2013-09-30 $0.01B $-0.00B -7.14%
2013-06-30 $0.01B $-0.00B -16.67%
2013-03-31 $0.01B $-0.00B -30.00%
2012-12-31 $0.01B $-0.00B -50.00%
2012-09-30 $0.01B $-0.00B -50.00%
2012-06-30 $0.01B $-0.00B -37.50%
2012-03-31 $0.01B $-0.00B -37.50%
2011-12-31 $0.01B $-0.00B -37.50%
2011-09-30 $0.01B $-0.00B -37.50%
2011-06-30 $0.01B $-0.00B -50.00%
2011-03-31 $0.01B $-0.00B -50.00%
2010-12-31 $0.01B $-0.00B -57.14%
2010-09-30 $0.01B $-0.00B -66.67%
2010-06-30 $0.01B $-0.00B -80.00%
2010-03-31 $0.00B $-0.00B -100.00%
2009-12-31 $0.00B $-0.00B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00